Back to Search
MATTHEW KEEFER, MD
MD
Pediatrics Physician
NPI: 1972609352Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
A74609(CA)
Research & Publications (20)
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
PMID 19298995·Virology·2009
8-other
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
PMID 18996425·Vaccine·2009
3-trial
Transporting juvenile salmonids around dams impairs adult migration.
PMID 19263886·Ecol Appl·2008
7-preclinical
Effects of modified short-leg walkers on ground reaction force characteristics.
PMID 18701198·Clin Biomech (Bristol)·2008
8-other
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.
PMID 17145123·Vaccine·2007
7-preclinical
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
PMID 17106277·J Acquir Immune Defic Syndr·2007
3-trial
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime.
PMID 17868958·Vaccine·2007
7-preclinical
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
PMID 16136469·J Infect Dis·2005
3-trial
Hispanic women's perceptions of patient-centeredness during prenatal care: a mixed-method study.
PMID 16336373·Birth·2005
4-observational
Establishment of an alternative intracellular cytokine staining assay for HIV/AIDS clinical studies.
PMID 15620394·J Virol Methods·2005
8-other
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
PMID 15031791·J Infect Dis·2004
3-trial
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
PMID 15295694·J Infect Dis·2004
3-trial
Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
PMID 12798637·Vaccine·2003
3-trial
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
PMID 11873074·J Acquir Immune Defic Syndr·2002
3-trial
Constrictive pericarditis caused by candida glabrata in an immunocompetent patient: case report and review of literature.
PMID 12238580·Scand J Infect Dis·2002
5-case
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
PMID 11311997·Vaccine·2001
3-trial
Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production.
PMID 11348664·Immunol Lett·2001
3-trial
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
PMID 11228380·Vaccine·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4650 W SUNSET BLVD
LOS ANGELES, CA 90027 - Phone
- (323) 669-2534
Quick Facts
- NPI
- 1972609352
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile